Professional pharmacy services and patient complexity: an observational study
Ignacy TA, Camacho X, Mamdani M, Juurlink D, Paterson M, Gomes T. J Pharm Pharm Sci. 2015; 18(5):863-70.
Publications
Trends in the coprescription of proton pump inhibitors with clopidogrel: an ecological analysis
Juurlink DN, Gomes T, Paterson JM, Hellings C, Mamdani MM. CMAJ Open. 2015; 3(4): E428-31.
Fluoroquinolones and collagen associated severe adverse events: a longitudinal cohort study
Daneman N, Lu H, Redelmeier DA. BMJ Open. 2015; 5(11):e010077. Epub 2015 Nov 18.
The hypoglycemic risk of glyburide (glibenclamide) compared with modified-release gliclazide
Clemens KK, McArthur E, Dixon SN, Fleet JL, Hramiak I, Garg AX. Can J Diabetes. 2015; 39(Suppl 4):32-40.
Examining exposure misclassification of oral bisphosphonate therapy and the associated fracture risk: a cohort study
Burden AM, Gruneir A, Paterson JM, Cadarette SM. Adv Pharmacoepidemiol Drug Saf. 2015; 4:4.
Osteoporosis management and fractures in the Métis of Ontario, Canada
Jandoc R, Jembere N, Khan S, Russell SJ, Allard Y, Cadarette SM. Arch Osteoporos. Epub 2015 Apr 25.
Safety of valproic acid in patients with chronic obstructive pulmonary disease: a population-based study
Antoniou T, Yao Z, Camacho X, Mamdani MM, Juurlink DN, Gomes T. Pharmacoepidemiol Drug Saf. 2015; 24(3):256-61. Epub 2015 Feb 5.
Initial uptake of the Ontario Pharmacy Smoking Cessation Program
Wong L, Burden AM, Liu YY, Tadrous M, Pojskic N, Dolovich L, Calzavara A, Cadarette SM. Can Pharm J. 2015; 148(1):29-40. Epub 2014 Dec 17.
Adherence to osteoporosis pharmacotherapy is underestimated using days supply values in electronic pharmacy claims data
Burden AM, Paterson JM, Gruneir A, Cadarette SM. Pharmacoepidemiol Drug Saf. 2015; 24(1):67-74. Epub 2014 Oct 21.
Adverse cardiac events in older patients receiving venlafaxine: a population-based study
Ho JM, Gomes T, Straus SE, Austin PC, Mamdani M, Juurlink DN. J Clin Psychiatry. 2014;75(6):e552-8.